Mastopexy Market Research, 2031
The global mastopexy market size was valued at $3.2 billion in 2021, and is projected to reach $5.9 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. A breast lift with implants, which is medically referred to as a mastopexy with breast augmentation, is a plastic surgery procedure designed to elevate/reshape sagging breasts, enhance breast fullness, reposition drooping nipples, and improve breast symmetry. The procedure can involve the use of a breast implant to increase the volume of the breast. When there is mild sagging to the breasts, an implant alone can produce a rejuvenated appearance with only a minimal skin incision. Any incision, however, can result in permanent scars. The procedure can restore a more youthful-looking shape to the breast.
Mastopexy surgeries are conducted owing to following reason, as the person get older, the breasts change, losing elasticity and firmness. There are many causes for these kinds of breast changes, including, pregnancy, as during pregnancy, the ligaments that support the breasts might stretch and the breasts get fuller and heavier. This stretching might contribute to sagging breasts after pregnancy. Weight fluctuation is another reason, changes in the weight can cause the breast skin to stretch and lose elasticity and over time, gravity causes ligaments in the breasts to stretch and sag.
To cure such problems mentioned above breast lift procedures can be performed in a variety of ways with different types of incisions. The approximate location of the incisions and scars are expected to be outlined directly on the skin with a medical skin marker or on a diagram. For a small uplift, short incisions just around the nipple areola may be necessary. The more the breasts sag, the more the patient is expected to need longer incisions. Most patients are between 30 and 60 years of age and want to make aesthetic enhancements to their breasts. The procedure can be performed as part of a post-mastectomy breast reconstruction procedure to achieve better symmetry with the reconstructed opposite breast.
The market is expected to witness a moderate growth during the forecast period, due to rise in female geriatric population, which is directly proportional to the increase in mastopexy procedures. Moreover, considering age as one of the segments in breast lift surgical procedures, it has been noted that around 40% of the total procedure is performed for age 40-54 years, followed by 27% of total procedure for age 30-39. This is expected to lead to significant growth of the market in the near future.
However, factors such as high cost of the treatment and post-surgical risk associated are expected to hamper the growth of the market to some extent during the forecast period.
The mastopexy market size is segmented on the basis of type, end use and region. On the basis of type, the market is segmented into benelli lift or donut lift, crescent breast lift, lollipop lift and anchor lift. On the basis of end use, it is divided into hospitals and specialty clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type Segment review
By type, the mastopexy market share is segmented into benelli lift or donut lift, crescent breast lift, lollipop lift and anchor lift. The anchor lift segment was the highest revenue contributor to the market in 2021. Increase in breast cancer cases and rise in number of cases of sagging breasts due to weight loss or pregnancy led to increase in number of mastopexy procedures to get back the natural shape of the breasts, which is expected to help in the growth of mastopexy market.
The benelli lift or donut lift is expected to be the fastest growing segment during the forecast period. Increase in demand for benelli lift procedure as women are seeking breast enhancement surgeries to boost their self-confidence and body image by updating their looks are the factors that propel the growth of the market.
End Use Segment Review
By end use, the hospitals segment was the highest revenue contributor to the market. Due to increase the demand for breast surgery for breast uplift and breast augmentation the demand of hospitals also increases to provide health care service to the patients which contributes in the growth of mastopexy market. For instance, according, to the Aesthetic Society, breast procedures such as breast augmentation, breast lift (mastopexy), breast reductions and combinations of the three were up by 48%. For example, there were 365,000 breast augmentations performed in 2021 (+44%). Specialized face procedures such as brow lifts and face lifts increased 54%.
The specialty clinics segment is expected to be the fastest growing segment during the forecast period. The pandemic has changed the way people live and there has been a shift in preferences; an increasing number of people are now turning to specialty clinics that have a wide range of well-equipped latest equipment for the surgical procedure, which contributes in the mastopexy market growth.
Region Segment Review
Region wise, the mastopexy industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America market was dominant, in terms of revenue among other regions in 2021, owing to increase in the number of breast augmentation surgical procedure conducted and increase in number of breasts cancer patients in this region.
Asia-Pacific is estimated to witness growth during the forecast period. Surge in demand for medical tourism owing to its low-cost leads to increase in number of surgical procedures in the region, which fuels the growth of the market. In addition, increase in development of breast implants to fulfil the unmet medical needs and burgeoning demand for personalized aesthetics products are the factors that propel the growth of the market
Key players operating in the global mastopexy market analysis include AbbVie, Bausch Health, Establishment Labs, GC Aesthetics, Guangzhou Wanhe Plastic Materials, Hologic, Mentor (Johnson & Johnson), Lipoelastic, Polytech Health & Aesthetics and Sientra Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the mastopexy market opportunity, and the current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the mastopexy market trends from 2022 to 2031 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the mastopexy market forecast based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the mastopexy industry
Mastopexy Market Report Highlights
| Aspects | Details |
 By Type |
|
 By End Use |
|
 By Region |
|
 Key Market Players | Abbvie Inc, BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL), Sientra Inc, JOHNSON & JOHNSON (MENTOR), GC Aesthetics, Hologic, Inc., Establishment Labs, LIPOELASTIC, GUANGZHOU WANHE PLASTIC MATERIALS, polytech health & aesthetics |
Analyst Review
This section provides various opinions of top-level CXOs in the mastopexy market. In accordance with several interviews conducted, the mastopexy market is expected to witness a significant growth in the future, owing to increase in prevalence of breast-cancer patients.
According to the perspectives of CXOs, the global mastopexy market is expected to witness a steady growth in the future. Increase in number of breast augmentation, breast up-lift and breast implant removal/reconstruction due to rise in female geriatric population are some of the factors that drive the growth of the market. However, high cost of the treatment and complications associated post-surgery are expected to hamper the growth of the market during the forecast period. Moreover, according to, The Aesthetic Society report, 2020-2021, around 364,753 breast augmentation procedures were conducted in 2021, which contributed around 15% of the total surgical revenue.
On the contrary, rise in advancements in technology of surgical procedures conducted is expected to provide opportunities for the growth of the global mastopexy market in future.
Further, North America is expected to witness highest growth, in terms of revenue, according to the American Society of Plastic Surgeons, breast augmentation continues to be one of the top five cosmetic surgical procedures among Americans since 2006. Silicone implants were used in 84% and saline implants in 16% of all breast augmentations in 2020. Increase in demand for breast augmentation procedure and increased advancement in the development of breast implants are the factors that propel the growth of the market.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to surge in medical tourism facilities, which leads to increase in the number of surgical procedures in the region.
Few major trends include the increased usage of silicone breast implants in breast lift and the increase in surgical procedures in Asia Pacific countries such as Malaysia, India, Thailand and Singapore due it rise in medical tourism
North America region dominated the market in 2021 due to its high cost of surgical procedures and the rise in cosmetic surgeries such as breast augmentation and breast lift.
The global mastopexy market was valued at $3,211.3 million in 2021, and is projected to reach $5,876.9 million by 2031, registering a CAGR of 6.3% from 2022 to 2031.
Mentor (Johnson & Johnson), Sientra INC and Lipoelastic are few companies to hold major share in the mastopexy market in 2021.
Key impacting factors include rise in breast cancer cases coupled with the rise in old aged women who needs breast lift suregry such as Benelli Lift or Crescent Breast Lift.
Benelli lift or donut lift is the most commonly used mastopexy procedure globally.This is majorly due to its unique advantage such as the reshaping areolas.
Few key strategies implemented by major players include product launch, partnership, acquisition and business expansion.
Few key factors such as high cost of surgery & implants, post surgery complications, risk of contracting infections and accumulation of fluid in breast might restrict the growth of the market
Loading Table Of Content...
